Gentronix Now Operating Under the Scantox Brand Accessibility StatementSkip Navigation "The way our industry assesses mutagenic risk is changing, and Scantox is helping to define what comes next," said Matt Tate, Chief Business Development Officer at Scantox. "With Big Blue®, Enhanced Ames Test, and now DuplexSeqâ"¢ under one roof, we can support sponsors with genomic safety data from early decision- making through regulatory submission—using the right tool at the right stage. That's not something any o ...